← Eichor
Study identifier: NCT05009771 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Postoperative Pain Management of Caesarean Section

Condition: Postoperative Pain · Caesarean Section · Analgesia  ·  Sponsor: Mackay Memorial Hospital

PhaseN/A
Planned participants100
Who can joinFemale, 20 Years to 40 Years
Healthy volunteersNo

About this study

Caesarean section is one of the most frequent surgeries causing severe postoperative pain. Poor management of acute pain can contribute to postoperative complications, late recovery and the development of chronic pain. Moreover, it had been demonstrated that the intensity of postpartum pain is associated with depression. It is imperative to find out appropriate methods of postpartum pain alleviation. Currently, a lot of analgesic drugs and methods have been developed and used in clinical practice, such as patient-controlled analgesia, extended-release analgesics and multimodal analgesia. This prospective cohort study is aimed to investigate the outcome of each postoperative analgesic method used in caesarean section.

This description comes directly from the study's public registry record.

Talk to the study team

Chi-Hsu Wang, M.D.  ·  +886-2-2809-4661  ·  s871017@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

MacKay Memorial Hospital Tamsui BranchNew Taipei City, Taiwan, TaiwanRecruiting
MacKay Memorial HospitalTaipei, Taiwan, TaiwanNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05009771